Merck's New Cancer Drug Shows Strong Results in Phase 3 Trials

Merck announced that its new cancer drug, sac-TMT, has demonstrated strong results in phase 3 trials. The drug offers new hope for patients battling advanced or recurrent aggressive endometrial cancers.

20 May, 11:00 — 20 May, 11:00

Post Share

Sources

Showing 1 of 1 sources

Fox NewsMixed101d ago

New drug approach offers hope for patients with recurrent aggressive cancers

Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.

Read full article →

PERSPECTA

PERSPECTA

Merck's New Cancer Drug Shows Strong Results in Phase 3 Trials

Sources

New drug approach offers hope for patients with recurrent aggressive cancers

Related Stories

Partial Lunar Eclipse Captured by Stargazers Across Multiple Continents

Global Observers Watch Partial Lunar Eclipse Covering Most of Moon

Partial Lunar Eclipse Draws Global Viewers Despite Cloudy European Skies

Rare Partial Lunar Eclipse to Cast Red Glow Across Northern Skies

PERSPECTA